Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 35,151 | 15,646 | N/A | N/A |
| Marketable Securities | 2,000 | 3,500 | N/A | N/A |
| Receivables | 336 | 300 | N/A | N/A |
| TOTAL | $38,250 | $19,635 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 68 | 58 | N/A | N/A |
| Other Non-Current Assets | 132 | 131 | 0 | 0 |
| TOTAL | $200 | $189 | $N/A | $N/A |
| Total Assets | $38,449 | $19,824 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 3,395 | 42 | 0 | 0 |
| Accrued Expenses | 3,439 | 1,131 | N/A | N/A |
| TOTAL | $6,834 | $2,840 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | N/A | 1,667 | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,834 | $2,840 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 29,223 | N/A | N/A | N/A |
| Common Shares | 2 | 2 | N/A | N/A |
| Retained earnings | -57,565 | -30,696 | N/A | N/A |
| TOTAL | $31,615 | $16,984 | $N/A | $N/A |
| Total Liabilities And Equity | $38,449 | $19,824 | $0 | $0 |